Drug Type Small molecule drug |
Synonyms MDR-652 |
Target |
Action agonists |
Mechanism TRPV1 agonists(Transient receptor potential cation channel subfamily V member 1 agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Back Pain | Phase 1 | South Korea | 30 Jan 2022 | |
| Diabetic Neuropathies | Preclinical | South Korea | 30 Jan 2022 | |
| Neuralgia, Postherpetic | Preclinical | South Korea | 30 Jan 2022 |





